The role of paliperidone extended release for the treatment of bipolar disorder

Código QR

The role of paliperidone extended release for the treatment of bipolar disorder

Jehan Marino1, Clayton English2, Joshua Caballero1, Catherine Harrington11College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, 2College of Pharmacy, Albany College of Pharmacy and Health Sciences, Colchester, VT, USABackground: Bipolar disorder (BD) is a chronic, relapsing, episod...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marino J, English C, Caballero J, Harrington C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/3917233d38424cc5890b571a755f4255
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Role of paliperidone extended-release in treatment of schizoaffective disorder
por: Carla M Canuso, et al.
Publicado: (2010)

Role of extended release quetiapine in the management of bipolar disorders
por: Rayan K Al Jurdi, et al.
Publicado: (2010)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
por: El-Khalili N
Publicado: (2012)

Extended-release divalproex in bipolar and other psychiatric disorders: A comprehensive review
por: Steven C Stoner, et al.
Publicado: (2007)

Direct and indirect effects of paliperidone extended-release tablets on negative symptoms of schizophrenia
por: Ibrahim Turkoz, et al.
Publicado: (2008)

An open-label, prospective study to evaluate social function and overall improvement of extended-release paliperidone treatment in Thai schizophrenia patients
por: Charnsil C, et al.
Publicado: (2013)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa R, et al.
Publicado: (2015)

An open-label, flexible-dose study of paliperidone extended-release in Chinese patients with first-onset psychosis
por: Si TM, et al.
Publicado: (2015)

Paliperidone extended-release tablets in Chinese patients with schizophrenia: meta-analysis of randomized controlled trials
por: Cai SL, et al.
Publicado: (2015)

Profile of guanfacine extended release and its potential in the treatment of attention-deficit hyperactivity disorder
por: Martinez-Raga J, et al.
Publicado: (2015)

Effects of paliperidone extended release on hostility among Thai patients with schizophrenia
por: Jariyavilas A, et al.
Publicado: (2017)

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
por: Findling RL, et al.
Publicado: (2014)

Treatment satisfaction with paliperidone extended-release tablets: open-label study in schizophrenia patients dissatisfied with previous antipsychotic medication
por: Yang FD, et al.
Publicado: (2017)

Management of obsessive-compulsive disorder with fluvoxamine extended release
por: L&iacute;dia Ordacgi, et al.
Publicado: (2009)

Ziprasidone in the treatment of mania in bipolar disorder
por: Stephen E Nicolson, et al.
Publicado: (2007)

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
por: Pompili M, et al.
Publicado: (2011)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
por: Charles L Bowden
Publicado: (2011)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
por: Warren CG, et al.
Publicado: (2013)

Improvement in social and cognitive functioning associated with paliperidone extended-release treatment in patients with schizophrenia: a 24-week, single arm, open-label study
por: Shi C, et al.
Publicado: (2016)

Interaction between paliperidone extended release and TS-1&reg;, an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
por: Yasui-Furukori N, et al.
Publicado: (2013)

Once-monthly paliperidone injection for the treatment of schizophrenia
por: Delia Bishara
Publicado: (2010)

Efficacy, safety, and potential of extended-release lamotrigine in the treatment of epileptic patients
por: Barbara Błaszczyk, et al.
Publicado: (2010)

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
por: Joseph Biederman, et al.
Publicado: (2008)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
por: McIntyre R, et al.
Publicado: (2011)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
por: Prashant Gajwani, et al.
Publicado: (2007)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009)

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia
por: Jeffrey R Bishop, et al.
Publicado: (2008)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
por: Jean-Michel Azorin, et al.
Publicado: (2010)

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
por: Mannu P, et al.
Publicado: (2011)

The management of schizophrenia: focus on extended-release quetiapine fumarate
por: Peuskens J
Publicado: (2011)

Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder
por: Endicott J, et al.
Publicado: (2012)

The efficacy of Li in bipolar disorder
por: Lozano R, et al.
Publicado: (2013)

Bipolar disorder and neurophysiologic mechanisms
por: Simon M McCrea
Publicado: (2008)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong JH, et al.
Publicado: (2015)

Safety and efficacy of paliperidone extended-release in Chinese patients with schizophrenia: a 24-week, open-label extension of a randomized, double-blind, placebo-controlled study
por: Zhang H, et al.
Publicado: (2016)

Lurasidone as a potential therapy for bipolar disorder
por: Woo YS, et al.
Publicado: (2013)

Correlates of current suicide risk among Thai patients with bipolar I disorder: findings from the Thai Bipolar Disorder Registry
por: Suttajit S, et al.
Publicado: (2013)

Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection
por: Wissam El-Hage, et al.
Publicado: (2010)

Retrospective analysis of factors associated with quetiapine dosage in the acute and subsequent six-month maintenance treatment of bipolar disorders
por: Zhang L, et al.
Publicado: (2013)